EQNCX
Price
$23.46
Change
+$0.14 (+0.60%)
Updated
Oct 17 closing price
Net Assets
674.51M
RMFCX
Price
$61.51
Change
+$0.17 (+0.28%)
Updated
Oct 17 closing price
Net Assets
111.18B
Interact to see
Advertisement

EQNCX vs RMFCX

Header iconEQNCX vs RMFCX Comparison
Open Charts EQNCX vs RMFCXBanner chart's image
MFS Equity Income C
Price$23.46
Change+$0.14 (+0.60%)
VolumeN/A
Net Assets674.51M
American Funds American Mutual R3
Price$61.51
Change+$0.17 (+0.28%)
VolumeN/A
Net Assets111.18B
EQNCX vs RMFCX Comparison Chart in %
View a ticker or compare two or three
VS
EQNCX vs. RMFCX commentary
Oct 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EQNCX is a Buy and RMFCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 111B vs. EQNCX (675M). RMFCX (1.20) and EQNCX (1.19) have matching dividends . EQNCX was incepted earlier than RMFCX: EQNCX (13 years) vs RMFCX (23 years). EQNCX (1.70) is less costly to investors than RMFCX (0.91). EQNCX is a more actively managed with annual turnover of: 40.00 vs. RMFCX (31.00). RMFCX has a lower initial minimum investment than EQNCX: RMFCX (250) vs EQNCX (1000). RMFCX annual gain was more profitable for investors over the last year : 4.96 vs. EQNCX (4.60). RMFCX return over 5 years is better than : 57.10 vs. EQNCX (53.08).
EQNCXRMFCXEQNCX / RMFCX
Total Expense Ratio1.640.91180%
Annual Report Gross Expense Ratio1.700.91187%
Fund Existence13 years23 years-
Gain YTD12.64613.68992%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets675M111B1%
Annual Yield % from dividends1.191.2099%
Returns for 1 year4.604.9693%
Returns for 3 years39.4938.79102%
Returns for 5 years53.0857.1093%
Returns for 10 years96.7991.18106%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
GRF11.110.36
+3.35%
Eagle Capital Growth Fund
PBE72.230.49
+0.68%
Invesco Biotechnology & Genome ETF
APIE36.000.20
+0.56%
ActivePassive International Equity ETF
IVV667.693.71
+0.56%
iShares Core S&P 500 ETF
IBGA25.48-0.05
-0.19%
iShares iBonds Dec 2044 Term Trsy ETF